CAS No.: 143851-98-3
Elacridar HCl Catalog No. CSN13175
Synonyms: GF120918A;GF-120918;GG 918
Elacridar HCl is a P-glycoprotein (P-gp) inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P-gp to investigate the role of transporters in the disposition of various test molecules.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Sane R, Mittapalli RK, et al. Development and evaluation of a novel microemulsion formulation of elacridar to improve its bioavailability. J Pharm Sci. 2013 Apr;102(4):1343-54.
- [2] Tang SC, Lagas JS, et al. Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration. Int J Cancer. 2012 Jan 1;130(1):223-33.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 143851-98-3 | 储存条件 |
|
|
| 分子式 | C34H34ClN3O5 | 运输 | 蓝冰 | |
| 分子量 | 600.10 | 别名 | GF120918A;GF-120918;GG 918 |
